ROBOTICS & AUTOMATION
Empowering Progress
Up to 25% off Essentials Robotics and Automation titles
Deprescribing and Polypharmacy in an Aging Population
- 1st Edition - August 22, 2023
- Author: Ali Elbeddini
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 9 9 1 3 8 - 4
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 9 3 8 1 - 4
Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated proble… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteDeprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population.
- Emphasizes the importance of involving a multidisciplinary team in deprescribing efforts
- Identifies barriers and enablers for the implementation of deprescribing programs
- Develops strategies to address barriers and optimize enablers for deprescribing implementation
Healthcare professionals involved in the circle of care and Pharmacy and medical school students & residents and professors, Hospital leadership and Policy makers
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Chapter 1: A global overview of the current state of deprescribing
- Abstract
- A global overview of the current state of deprescribing
- Practice questions: Test your understanding
- References
- Chapter 2: Health policies and deprescribing: An introduction to health policies, knowledge translation, and the barriers, challenges, and enablers to health policy implementation
- Abstract
- Health policies
- Necessary changes for effective deprescribing
- Who should be involved in deprescribing?
- Practice questions: Test your understanding
- References
- Chapter 3: Deprescribing is an essential part of prescribing
- Abstract
- What is polypharmacy?
- What is deprescribing?
- The prescribing cascade
- The deprescribing process
- Physiological changes in an older adult
- Medications commonly considered in deprescribing
- Tools for deprescribing
- References
- Chapter 4: Deprescribing in school curriculums: An overview of current education standards and what should be changed
- Abstract
- Introduction to deprescribing
- Who is involved with deprescribing?
- Current state of deprescribing
- Deprescribing: The Canadian school perspective
- Future directions
- Learning how to learn
- Expanding beyond Canada
- Concluding notes
- References
- Chapter 5: The role of the multidisciplinary healthcare team in deprescribing
- Abstract
- Overview of polypharmacy and deprescribing
- The multidisciplinary team approach in deprescribing
- Weighing the risks and benefits of deprescribing
- Developing the deprescribing plan
- Deprescribing high-risk medications
- Comprehensive geriatric assessments
- Strengths and weaknesses of multidisciplinary teams
- Communication strategies in multidisciplinary deprescribing teams
- Implementing changes in the hospital setting
- Conclusion
- References
- Chapter 6: Looking to the future: Artificial intelligence in enhancing patient care
- Abstract
- Background
- Developments in medicine
- Conclusion
- References
- Chapter 7: Challenges/barriers of deprescribing during COVID-19
- Abstract
- Overview of healthcare challenges unique to the COVID-19 pandemic
- Physical distancing guidelines
- Increased demands on the healthcare system
- The impact of COVID-19 on mental health
- Deprescribing practice during the COVID-19 pandemic
- Challenges to deprescribing practice during the COVID-19 pandemic
- Physical/social distancing
- The need for extensive patient monitoring
- Information overload/theoretical harm
- Strategies for overcoming barriers of deprescribing during COVID-19
- Application of COVID-19 guidance
- Simplifying medication regimens
- Providing stakeholders with adequate information
- Conclusion
- References
- Chapter 8: Deprescribing in palliative care and Alzheimer’s patients: Optimizing medication use for improved quality of life
- Abstract
- Introduction
- Deprescribing in patients under palliative care
- Deprescribing in Alzheimer’s disease
- Conclusion
- References
- Index
- No. of pages: 350
- Language: English
- Edition: 1
- Published: August 22, 2023
- Imprint: Academic Press
- Paperback ISBN: 9780323991384
- eBook ISBN: 9780323993814
AE
Ali Elbeddini
Dr. Elbeddini is Affiliate Investigator in Epidemiology at Ottawa Hospital Research Institute (OHRI), Canada. He previously an Assistant Professor in Clinical Pharmacy at Skaggs School of Pharmacy, University of Colorado, USA and conducted post-doctorate research at Harvard Medical School (HMS) in Global Clinical Scholars Research Education program.
Affiliations and expertise
Assistant Professor, Family Medicine, Faculty of Medicine, University of Ottawa, CanadaRead Deprescribing and Polypharmacy in an Aging Population on ScienceDirect